AstraZeneca PLC AZN
183.88 USD -2.70 (-1.45%)
At closeNov 4, 2026, 4:23 AM EST
184.45 +0.57 +0.31%
Pre-market · Nov 4, 4:23 AM ET
182.95 Day range 187.35
153.41 52-week range 212.71
- YTD
- +0.01%
- 1 year
- +12.08%
Analyst view
Consensus: buy
Buy
Price target (mean) 206.66 +12.4% upside
Now 183.88
- Target (low)
- 158.00
- Target (mean)
- 206.66
- Target (high)
- 240.00
Ratings (0m) 12 9 buy · 2 hold · 1 sell
- Strong buy2
- Buy7
- Hold2
- Sell1
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 11
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.74 | 1.74 – 1.74 | 0.00 | 0.0% | 16.56B | +6.9% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 15.98B | +4.5% | 0 |
| Current year | 10.12 | 10.08 – 10.16 | 4.58 | +121.0% | 63.35B | +7.8% | 2 |
| Next year | 11.32 | 10.83 – 11.84 | 10.12 | +11.8% | 67.38B | +6.4% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 24, 2026 | CICC | Initiated | — | Outperform |
| Feb 13, 2025 | UBS | Upgrade | Neutral | Buy |
| Nov 20, 2024 | UBS | Upgrade | Sell | Neutral |
| Sep 11, 2024 | Erste Group | Upgrade | Hold | Buy |
| Aug 12, 2024 | TD Cowen | Maintained | Buy | Buy |
| May 30, 2024 | Argus Research | Maintained | Buy | Buy |
| May 30, 2024 | Goldman Sachs | Initiated | — | Buy |
| Apr 26, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Apr 16, 2024 | Deutsche Bank | Upgrade | Sell | Hold |
| Feb 12, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 8, 2024 | Deutsche Bank | Downgrade | Buy | Hold |
| Jan 23, 2024 | Morgan Stanley | Initiated | — | Overweight |
| Jan 3, 2024 | Jefferies | Downgrade | Buy | Hold |
| Sep 25, 2023 | Jefferies | Upgrade | Hold | Buy |
| Sep 8, 2023 | Erste Group | Downgrade | Buy | Hold |
| Aug 1, 2023 | BMO Capital | Maintained | Outperform | Outperform |
| May 26, 2023 | Argus Research | Maintained | Buy | Buy |
| Apr 13, 2023 | Argus Research | Maintained | — | Buy |
| Jan 5, 2023 | BMO Capital | Initiated | — | Outperform |
| Nov 14, 2022 | SVB Leerink | Maintained | — | Outperform |
| Nov 11, 2022 | SVB Leerink | Maintained | — | Outperform |
| Aug 29, 2022 | Argus Research | Upgrade | Hold | Buy |
| May 4, 2022 | SVB Leerink | Maintained | — | Outperform |
| Feb 24, 2022 | SVB Leerink | Maintained | — | Outperform |
| Feb 11, 2022 | DZ Bank | Upgrade | Sell | Hold |
| Dec 7, 2021 | Jefferies | Downgrade | Buy | Hold |
| Sep 27, 2021 | SVB Leerink | Maintained | — | Outperform |
| Sep 20, 2021 | SVB Leerink | Maintained | — | Outperform |
| Aug 4, 2021 | SVB Leerink | Maintained | — | Outperform |
| Jul 16, 2021 | SVB Leerink | Maintained | — | Outperform |